Nisa Investment Advisors, LLC Halozyme Therapeutics, Inc. Transaction History

Nisa Investment Advisors, LLC

$16.7 Billion
Q3 2024

A detailed history of Nisa Investment Advisors, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 5,495 shares of HALO stock, worth $258,045. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,495

Previous 4,137 32.83%

Holding current value

$258,045

Previous $216,000 45.37%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$51.3 - $64.42 $69,665 - $87,482	1,358 Added 32.83%	5,495 $314,000
Q2 2024 Jul 19, 2024	BUY	$37.81 - $52.4 $4,045 - $5,606	107 Added 2.66%	4,137 $216,000
Q1 2024 May 01, 2024	BUY	$33.68 - $41.95 $2,660 - $3,314	79 Added 2.0%	4,030 $163,000
Q4 2023 Jan 25, 2024	SELL	$33.32 - $42.1 $63,108 - $79,737	-1,894 Reduced 32.4%	3,951 $146,000
Q3 2023 Nov 02, 2023	SELL	$36.46 - $44.03 $1,057 - $1,276	-29 Reduced 0.49%	5,845 $223,000
Q2 2023 Aug 11, 2023	BUY	$30.28 - $38.74 $8,508 - $10,885	281 Added 5.02%	5,874 $211,000
Q1 2023 May 02, 2023	SELL	$32.86 - $55.7 $37,131 - $62,941	-1,130 Reduced 16.81%	5,593 $214,000
Q3 2022 Nov 07, 2022	SELL	$38.53 - $51.78 $2,620 - $3,521	-68 Reduced 1.0%	6,723 $300,000
Q1 2022 Apr 29, 2022	BUY	$31.97 - $41.06 $32,609 - $41,881	1,020 Added 17.67%	6,791 $271,000
Q4 2021 Feb 03, 2022	SELL	$31.82 - $40.75 $7,604 - $9,739	-239 Reduced 3.98%	5,771 $200,000
Q3 2021 Oct 18, 2021	SELL	$38.47 - $46.42 $193,388 - $233,353	-5,027 Reduced 45.55%	6,010 $244,000
Q4 2020 Jan 25, 2021	BUY	$25.81 - $43.62 $93,535 - $158,078	3,624 Added 48.89%	11,037 $471,000
Q3 2020 Oct 20, 2020	SELL	$25.74 - $29.63 $209,883 - $241,603	-8,154 Reduced 52.38%	7,413 $195,000
Q2 2020 Jul 27, 2020	BUY	$16.25 - $26.81 $54,388 - $89,733	3,347 Added 27.39%	15,567 $417,000
Q1 2020 Apr 17, 2020	SELL	$13.9 - $21.83 $82,427 - $129,451	-5,930 Reduced 32.67%	12,220 $220,000
Q4 2019 Jan 17, 2020	BUY	$14.93 - $19.53 $16,721 - $21,873	1,120 Added 6.58%	18,150 $322,000
Q3 2019 Oct 17, 2019	BUY	$15.2 - $17.69 $173,280 - $201,666	11,400 Added 202.49%	17,030 $264,000
Q3 2018 Oct 16, 2018	SELL	$16.68 - $18.41 $2,335 - $2,577	-140 Reduced 2.43%	5,630 $102,000
Q1 2018 Apr 10, 2018	SELL	$17.06 - $21.2 $5,971 - $7,420	-350 Reduced 5.72%	5,770 $113,000
Q3 2017 Oct 13, 2017	BUY	$11.76 - $17.4 $71,971 - $106,487	6,120	6,120 $106,000

Others Institutions Holding HALO

# of Institutions

543

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.54B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.

Account

Nisa Investment Advisors, LLC Halozyme Therapeutics, Inc. Transaction History